PLASMAFLO OP-05 W(A) ASAHI PLASMA SEPARATOR

Separator For Therapeutic Purposes, Membrane Automated Blood Cell/plasma

FDA Premarket Approval P820033

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

DevicePLASMAFLO OP-05 W(A) ASAHI PLASMA SEPARATOR
Classification NameSeparator For Therapeutic Purposes, Membrane Automated Blood Cell/plasma
Generic NameSeparator For Therapeutic Purposes, Membrane Automated Blood Cell/plasma
ApplicantAsahi Kasei Medical Co., Ltd.
Date Received1982-05-26
Decision Date1983-07-05
Notice Date1983-08-12
PMAP820033
SupplementS
Product CodeMDP
Docket Number83M-0236
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address Asahi Kasei Medical Co., Ltd. 1-105 Kanda Jinbocho chiyoda-ku tokyo 101-8-8101

Supplemental Filings

Supplement NumberDateSupplement Type
P820033Original Filing
S016 2022-12-09 30-day Notice
S015 2022-01-11 30-day Notice
S014 2021-02-01 30-day Notice
S013 2020-09-24 30-day Notice
S012 2018-01-19 30-day Notice
S011 2017-12-20 30-day Notice
S010 2016-02-19 30-day Notice
S009 2015-11-06 30-day Notice
S008 2011-10-12 30-day Notice
S007 2010-12-15 30-day Notice
S006 2010-07-07 30-day Notice
S005 2009-08-18 Normal 180 Day Track
S004
S003
S002
S001 1984-04-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.